NEUROONE MEDICAL TECHNOLOGIES Corp Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Return On Equity for the quarter ending June 30, 2024 was -276 %, a 86.1% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Return On Equity for 2023 was -199 %, a 145% decline from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Return On Equity for 2022 was -81.1 %, a 43.6% increase from 2021.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Return On Equity for 2021 was -144 %, a 131% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -199 -118 -145% Oct 1, 2022 Sep 30, 2023
2022 -81.1 +62.6 +43.6% Oct 1, 2021 Sep 30, 2022
2021 -144 -612 -131% Oct 1, 2020 Sep 30, 2021
2020 468 +17.8 +3.94% Oct 1, 2019 Sep 30, 2020
2019 450 Oct 1, 2018 Sep 30, 2019
2017 230 +196 +569% Jan 1, 2017 Dec 31, 2017
2016 34.4 -71.5 -67.5% Jan 1, 2016 Dec 31, 2016
2015 106 -67.4 -38.9% Jan 1, 2015 Dec 31, 2015
2014 173 +53.2 +44.3% Jan 1, 2014 Dec 31, 2014
2013 120 +14.9 +14.2% Jan 1, 2013 Dec 31, 2013
2012 105 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.